Cyclin O Promotes the Proliferation and Metastasis of Cervical Cancer Cells by Regulating Glycolysis
-
摘要:
目的 探讨细胞周期蛋白O(cyclin O,CCNO)在宫颈癌中的表达及影响宫颈癌进展的分子机制。 方法 收集2018年1月至2023年12月期间蚌埠医科大学第一附属医院肿瘤妇科60例宫颈癌患者病理切片,免疫组化检测CCNO在宫颈癌中的表达。通过转染技术将实验分为Vector组、CCNO组、siNC和siCCNO组。通过CCK-8实验及克隆形成实验评估CCNO影响细胞增殖水平的能力。利用Transwell小室实验及划痕实验评估CCNO影响细胞侵袭及迁移能力。利用糖酵解实验及蛋白印迹实验评估CCNO对宫颈癌细胞糖酵解的影响。 结果 临床样本免疫组化及WB结果显示,CCNO在宫颈癌中高表达(P < 0.001)。实验发现过表达CCNO促进宫颈癌细胞增殖、侵袭、迁移及糖酵解的发生(P < 0.05),反之则抑制宫颈癌细胞增殖、侵袭、迁移及糖酵解(P < 0.05)。生信分析及WB实验结果显示,过表达CCNO可能通过激活PI3K/AKT信号通路调节宫颈癌的发生(P < 0.05)。 结论 细胞周期蛋白O可能通过调控糖酵解促进宫颈癌细胞增殖和转移。 -
关键词:
- CCNO /
- 糖酵解代谢 /
- 宫颈癌 /
- PI3K/AKT信号通路
Abstract:Objective To investigate the expression of Cyclin O (CCNO) in cervical cancer and its molecular mechanism in the progression of cervical cancer. Methods The pathological sections of 60 patients with cervical cancer in the Department of Oncology and Gynecology of the First Affiliated Hospital of Bengbu Medical University from January 2018 to December 2023 were collected, and the expression of CCNO in cervical cancer was detected by immunohistochemistry. The cells were divided into Vector group, CCNO group, siNC group and siCCNO group by transfection technology. CCK-8 assay and colony formation assay were used to evaluate the ability of CCNO to affect cell proliferation. Transwell assay and wound healing assay were used to evaluate the effect of CCNO on cell invasion and migration. Glycolysis assay and Western blot assay were used to evaluate the effect and mechanism of CCNO on glycolysis of cervical cancer cells. Results The results of immunohistochemistry and WB showed that CCNO was highly expressed in cervical cancer (P < 0.001). Overexpression of CCNO promoted the proliferation, invasion, migration and glycolysis of cervical cancer cells (P < 0.05), whereas the opposite effect inhibited the proliferation, invasion, migration and glycolysis of cervical cancer cells (P < 0.05). Bioinformatics analysis and WB results showed that CCNO overexpression may regulate the occurrence of cervical cancer by activating the PI3K/AKT signaling pathway (P < 0.05). Conclusion Cyclin O may promote the proliferation and metastasis of cervical cancer cells by regulating glycolysis. -
Key words:
- CCNO /
- Glycolysis and metabolism /
- Cervical cancer /
- PI3K/AKT signaling pathway
-
表 1 引物序列
Table 1. Primer sequence
基因名称 上游 下游 CCNO 5′- TCCAGTCAGGAGGCTGAGTT-3′ 5′-CAAAAGGCATTCCAGCATTT-3′ GAPDH 5′-GCACCGTCAAGGCTGAGAAC-3′ 5′-TGGTGAAGACGCCAGTGGA-3′ 表 2 CCNO在宫颈癌组织及癌旁组织中的表达水平[n (%)]
Table 2. Expression levels of CCNO in Cervical cancer tissues and adjacent tissues[n (%)]
CCNO表达 癌组织(n=60) 癌旁组织(n=60) χ2 P 阳性 48(80.0) 8(13.3) 53.571 < 0.001* 阴性 12(20.0) 52(86.7) *P < 0.05。 表 3 宫颈癌患者CCNO表达与临床资料的关系(n)
Table 3. Relationship between CCNO expression and clinical data in patients with cervical cancer (n)
特征 n CCNO 表达 χ2 p 高 低 年龄(岁) 0.268 0.605 < 50 32 17 15 ≥50 28 13 15 HPV感染 1.086 0.297 阴性 34 19 15 阳性 26 11 15 肿瘤大小(cm) 6.787 0.009* < 3 26 8 18 ≥3 34 22 12 FIGO分期 4.344 0.037* Ⅰ 26 9 17 Ⅱ~Ⅲ 34 21 13 淋巴结转移 8.076 0.004* 有 31 21 10 无 29 9 20 组织类型 3.300 0.069 鳞癌 27 17 10 腺癌 33 13 20 *P < 0.05。 -
[1] Bray F,Laversanne M,Sung H,et al. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin,2024,74(3):229-263. doi: 10.3322/caac.21834 [2] Siegel R L,Miller K D,Wagle N S,et al. Cancer statistics,2023[J]. CA:A Cancer J Clinicians,2023,73(1):17-48. doi: 10.3322/caac.21763 [3] Xia C,Dong X,Li H,et al. Cancer statistics in China and United States,2022: Profiles,trends,and determinants[J]. Chin Med J (Engl),2022,135(5):584-590. doi: 10.1097/CM9.0000000000002108 [4] Chen C Y, Chen W C, Mohamed M G,et al. Highly thermally stable,reversible,and flexible main chain type benzoxazine hybrid Incorporating both polydimethylsiloxane and double-decker shaped polyhedral silsesquioxane units through diels-alder reaction[J]. Macromol Rapid Commun,2023,44(10):e2200910. doi: 10.1002/marc.202200910 [5] Oaknin A,Moore K,Meyer T,et al. Nivolumab with or without ipilimumab in patients with recurrent or metastatic cervical cancer (CheckMate 358): A phase 1-2,open-label,multicohort trial[J]. Lancet Oncol,2024,25(5):588-602. doi: 10.1016/S1470-2045(24)00088-3 [6] Jiang J,Yu W,Fang T,et al. Cyclin O promotes lung cancer progression and cetuximab resistance via cell cycle regulation and CDK13 interaction[J]. J Thorac Dis,2023,15(4):2167-2183. doi: 10.21037/jtd-23-437 [7] Li L,Cao Y,Zhou H,et al. Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis[J]. Onco Targets Ther,2018,11:7471-7481. doi: 10.2147/OTT.S176252 [8] Amirav I,Wallmeier J,Loges N T,et al. Systematic analysis of CCNO variants in a defined population: Implications for clinical phenotype and differential diagnosis[J]. Hum Mutat,2016,37(4):396-405. doi: 10.1002/humu.22957 [9] Roig M B,Roset R,Ortet L,et al. Identification of a novel cyclin required for the intrinsic apoptosis pathway in lymphoid cells[J]. Cell Death Differ,2009,16(2):230-243. doi: 10.1038/cdd.2008.145 [10] Ma J Y,Ou-Yang Y C,Luo Y B,et al. Cyclin O regulates germinal vesicle breakdown in mouse oocytes[J]. Biol Reprod,2013,88(5):110. [11] Wallmeier J,Al-Mutairi D A,Chen C T,et al. Mutations in CCNO result in congenital mucociliary clearance disorder with reduced generation of multiple motile Cilia[J]. Nat Genet,2014,46(6):646-651. doi: 10.1038/ng.2961 [12] Li L, Cao Y, Zhou H, et al. Knockdown of CCNO decreases the tumorigenicity of gastric cancer by inducing apoptosis[J]. Onco Targets Ther,2018,11:7471-7481. [13] 仲娣,刘子曈,李鹏,等. 宫颈癌组织中YTHDF1的表达及其临床意义[J]. 徐州医科大学学报,2024,44(8):553-558. doi: 10.12467/j.issn.2096-3882.20240315 [14] Song Z,Wei Z,Wang Q,et al. The role of DOT1L in the proliferation and prognosis of gastric cancer[J]. Biosci Rep,2020,40(1):BSR20193515. doi: 10.1042/BSR20193515 [15] Yao S,Zhao L,Chen S,et al. Cervical cancer immune infiltration microenvironment identification,construction of immune scores,assisting patient prognosis and immunotherapy[J]. Front Immunol,2023,14:1135657. doi: 10.3389/fimmu.2023.1135657 [16] Kamamoto S, Murayama A, Hamaki T, et al. HPV vaccination and cervical cancer screening.[J]. Lancet.,2022,399(10339):1939-1940. [17] Falcaro M,Soldan K,Ndlela B,et al. Effect of the HPV vaccination programme on incidence of cervical cancer and grade 3 cervical intraepithelial neoplasia by socioeconomic deprivation in England: Population based observational study[J]. BMJ,2024,385:e077341. [18] Rahangdale L,Mungo C,O'Connor S,et al. Human papillomavirus vaccination and cervical cancer risk[J]. BMJ,2022,379:e070115. [19] Wang J,Chen S. RACK1 promotes miR-302b/c/d-3p expression and inhibits CCNO expression to induce cell apoptosis in cervical squamous cell carcinoma[J]. Cancer Cell Int,2020,20:385. doi: 10.1186/s12935-020-01435-0 [20] Fujimura A,Michiue H,Cheng Y,et al. Cyclin G2 promotes hypoxia-driven local invasion of glioblastoma by orchestrating cytoskeletal dynamics[J]. Neoplasia,2013,15(11):1272-1281. doi: 10.1593/neo.131440 -
下载: